• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problems.用于耐药性尿路感染的呋喃妥因和磷霉素:应对新问题的老药
Aust Prescr. 2019 Feb;42(1):14-19. doi: 10.18773/austprescr.2019.002. Epub 2019 Feb 1.
2
An update on the management of urinary tract infections in the era of antimicrobial resistance.抗菌药物耐药时代泌尿道感染管理的最新进展
Postgrad Med. 2017 Mar;129(2):242-258. doi: 10.1080/00325481.2017.1246055. Epub 2016 Oct 21.
3
Oral treatment options for patients with urinary tract infections caused by extended spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae.产超广谱β内酰胺酶(ESBL)肠杆菌科导致的尿路感染患者的口服治疗选择。
J Infect Public Health. 2019 Nov-Dec;12(6):843-846. doi: 10.1016/j.jiph.2019.05.012. Epub 2019 Jun 6.
4
Fosfomycin Susceptibility in Multidrug-Resistant Enterobacteriaceae Species and Vancomycin-Resistant Enterococci Urinary Isolates.耐多药肠杆菌科细菌和耐万古霉素肠球菌尿液分离株中磷霉素的敏感性
Can J Hosp Pharm. 2017 Sep-Oct;70(5):368-374. doi: 10.4212/cjhp.v70i5.1698. Epub 2017 Oct 31.
5
Resistance to oral antibiotics in 4569 Gram-negative rods isolated from urinary tract infection in children.从儿童尿路感染中分离出的4569株革兰氏阴性杆菌对口服抗生素的耐药性。
Eur J Pediatr. 2016 Sep;175(9):1219-1225. doi: 10.1007/s00431-016-2763-1. Epub 2016 Aug 24.
6
Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial.呋喃妥因 5 天疗法与磷霉素单剂量疗法治疗女性单纯性下尿路感染临床缓解效果的随机临床试验。
JAMA. 2018 May 1;319(17):1781-1789. doi: 10.1001/jama.2018.3627.
7
Susceptibility of Nitrofurantoin and Fosfomycin Against Outpatient Urinary Isolates of Multidrug-Resistant Enterococci over a Period of 10 Years from India.10 年间,从印度分离的多药耐药肠球菌门诊分离株对呋喃妥因和磷霉素的敏感性。
Microb Drug Resist. 2020 Dec;26(12):1509-1515. doi: 10.1089/mdr.2019.0044. Epub 2019 Dec 2.
8
Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents.抗菌药物耐药性和新型抗菌药物时代的尿路感染治疗。
Postgrad Med. 2020 Apr;132(3):234-250. doi: 10.1080/00325481.2019.1680052. Epub 2019 Oct 24.
9
[National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients].[国家S3非复杂性尿路感染指南:成人患者非复杂性社区获得性细菌性尿路感染的治疗与管理建议]
Urologe A. 2011 Feb;50(2):153-69. doi: 10.1007/s00120-011-2512-z.
10
A cost-minimization analysis of treatment options for postmenopausal women with dysuria.绝经后女性排尿困难治疗选择的成本最小化分析。
Am J Obstet Gynecol. 2019 Nov;221(5):505.e1-505.e7. doi: 10.1016/j.ajog.2019.04.031. Epub 2019 May 2.

引用本文的文献

1
Understanding the Burden and Management of Urinary Tract Infections in Women.了解女性尿路感染的负担及管理
Diseases. 2025 Feb 15;13(2):59. doi: 10.3390/diseases13020059.
2
Associations between neighbourhood-level median household income and outpatients' risk of antibiotic non-susceptible uropathogens in a major urban centre, USA.美国一个主要城市中心邻里层面家庭收入中位数与门诊患者感染抗生素不敏感尿路病原体风险之间的关联。
JAC Antimicrob Resist. 2024 Nov 5;6(6):dlae179. doi: 10.1093/jacamr/dlae179. eCollection 2024 Dec.
3
Unlocking Nitrofurantoin: Understanding Molecular Mechanisms of Action and Resistance in Enterobacterales.解锁呋喃妥因:了解肠杆菌科细菌的分子作用机制及耐药性
Med Princ Pract. 2025;34(2):121-137. doi: 10.1159/000542330. Epub 2024 Oct 29.
4
The effect of antibiotic selection on collateral effects and evolvability of uropathogenic .抗生素选择对尿路致病性的附带效应和进化能力的影响
NPJ Antimicrob Resist. 2024;2(1):19. doi: 10.1038/s44259-024-00037-4. Epub 2024 Jul 17.
5
The Prevalence of Multidrug-Resistant in Chennai and Whole Genome Sequence Analysis of Carbapenem-Resistant ST410.钦奈多重耐药菌的流行情况及耐碳青霉烯类 ST410 的全基因组序列分析
Indian J Microbiol. 2024 Jun;64(2):467-474. doi: 10.1007/s12088-023-01125-1. Epub 2023 Nov 28.
6
Regional variations in antimicrobial susceptibility of community-acquired uropathogenic in India: Findings of a multicentric study highlighting the importance of local antibiograms.印度社区获得性尿路致病性细菌抗菌药物敏感性的区域差异:一项多中心研究的结果凸显了当地抗菌谱的重要性。
IJID Reg. 2024 Apr 25;11:100370. doi: 10.1016/j.ijregi.2024.100370. eCollection 2024 Jun.
7
Mitigating antimicrobial resistance, an approach to stewardship in canine urinary tract infection.减轻抗菌药物耐药性:犬下尿路感染管理策略。
Vet Res Commun. 2024 Aug;48(4):2145-2155. doi: 10.1007/s11259-024-10387-z. Epub 2024 Apr 22.
8
A review of the mechanisms that confer antibiotic resistance in pathotypes of .一种对赋予 病原菌抗生素耐药性的机制的综述。
Front Cell Infect Microbiol. 2024 Apr 4;14:1387497. doi: 10.3389/fcimb.2024.1387497. eCollection 2024.
9
Bacterial Persistence in Urinary Tract Infection Among Postmenopausal Population.绝经后人群尿路感染中的细菌持续存在。
Urogynecology (Phila). 2024 Mar 1;30(3):205-213. doi: 10.1097/SPV.0000000000001452. Epub 2024 Jan 15.
10
A Five-Year Analysis of Antibiotic Resistance Trends among Bacteria Identified in Positive Urine Samples in a Tertiary Care Hospital from Bucharest, Romania.罗马尼亚布加勒斯特一家三级护理医院对尿液阳性样本中鉴定出的细菌的抗生素耐药性趋势进行的五年分析。
Antibiotics (Basel). 2024 Feb 6;13(2):160. doi: 10.3390/antibiotics13020160.

本文引用的文献

1
Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial.呋喃妥因 5 天疗法与磷霉素单剂量疗法治疗女性单纯性下尿路感染临床缓解效果的随机临床试验。
JAMA. 2018 May 1;319(17):1781-1789. doi: 10.1001/jama.2018.3627.
2
Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections.感染病会诊可降低多重耐药菌感染患者30天和1年的全因死亡率。
Open Forum Infect Dis. 2018 Mar 15;5(3):ofy026. doi: 10.1093/ofid/ofy026. eCollection 2018 Mar.
3
Emerging Gram negative resistance to last-line antimicrobial agents fosfomycin, colistin and ceftazidime-avibactam - epidemiology, laboratory detection and treatment implications.革兰氏阴性菌对最后一线抗菌药物磷霉素、黏菌素和头孢他啶-阿维巴坦的新出现耐药性 - 流行病学、实验室检测和治疗意义。
Expert Rev Anti Infect Ther. 2018 Apr;16(4):289-306. doi: 10.1080/14787210.2018.1453807. Epub 2018 Mar 21.
4
Effect of outpatient antibiotics for urinary tract infections on antimicrobial resistance among commensal Enterobacteriaceae: a multinational prospective cohort study.门诊使用抗生素治疗尿路感染对共生肠杆菌科中抗菌药物耐药性的影响:一项多国家前瞻性队列研究。
Clin Microbiol Infect. 2018 Sep;24(9):972-979. doi: 10.1016/j.cmi.2017.12.026. Epub 2018 Jan 10.
5
Fosfomycin efficacy and emergence of resistance among Enterobacteriaceae in an in vitro dynamic bladder infection model.在体外动态膀胱感染模型中观察到肠杆菌科中磷霉素的疗效和耐药性的出现。
J Antimicrob Chemother. 2018 Mar 1;73(3):709-719. doi: 10.1093/jac/dkx441.
6
Urinary Tract Conditions Affect Fosfomycin Activity against Escherichia coli Strains Harboring Chromosomal Mutations Involved in Fosfomycin Uptake.尿路条件影响磷霉素对携带参与磷霉素摄取的染色体突变的大肠杆菌菌株的活性。
Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.01899-17. Print 2018 Jan.
7
Local epidemiology and resistance profiles in acute uncomplicated cystitis (AUC) in women: a prospective cohort study in an urban urological ambulatory setting.女性急性单纯性膀胱炎(AUC)的局部流行病学和耐药情况:一项在城市泌尿外科门诊环境中的前瞻性队列研究。
BMC Infect Dis. 2017 Oct 16;17(1):685. doi: 10.1186/s12879-017-2789-7.
8
High interindividual variability in urinary fosfomycin concentrations in healthy female volunteers.健康女性志愿者尿液磷霉素浓度的个体间变异性很大。
Clin Microbiol Infect. 2018 May;24(5):528-532. doi: 10.1016/j.cmi.2017.08.023. Epub 2017 Sep 1.
9
Fosfomycin and Comparator Activity Against Select Enterobacteriaceae, Pseudomonas, and Enterococcus Urinary Tract Infection Isolates from the United States in 2012.2012年美国磷霉素与对照药物对部分肠杆菌科细菌、铜绿假单胞菌及肠球菌尿路感染分离株的活性比较
Infect Dis Ther. 2017 Jun;6(2):233-243. doi: 10.1007/s40121-017-0150-5. Epub 2017 Mar 11.
10
Forgotten antibiotics: a follow-up inventory study in Europe, the USA, Canada and Australia.被遗忘的抗生素:在欧洲、美国、加拿大和澳大利亚的一项后续库存研究。
Int J Antimicrob Agents. 2017 Jan;49(1):98-101. doi: 10.1016/j.ijantimicag.2016.09.029. Epub 2016 Nov 16.

用于耐药性尿路感染的呋喃妥因和磷霉素:应对新问题的老药

Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problems.

作者信息

Gardiner Bradley J, Stewardson Andrew J, Abbott Iain J, Peleg Anton Y

机构信息

Department of Infectious Disease, Alfred Health and Central Clinical School, Monash University, Melbourne.

Department of Medical Microbiology and Infectious Diseases, Research and Development Unit, Erasmus Medical Centre, Rotterdam, The Netherlands.

出版信息

Aust Prescr. 2019 Feb;42(1):14-19. doi: 10.18773/austprescr.2019.002. Epub 2019 Feb 1.

DOI:10.18773/austprescr.2019.002
PMID:30765904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6370609/
Abstract

Uncomplicated urinary tract infection is one of the most common indications for antibiotic use in the community. However, the Gram-negative organisms that can cause the infection are becoming more resistant to antibiotics Many multidrug resistant organisms retain susceptibility to two old antibiotics, nitrofurantoin and fosfomycin. Advantages over newer drugs include their high urinary concentrations and minimal toxicity Fosfomycin is a potential treatment option for patients with uncomplicated urinary tract infection due to resistant organisms. Nitrofurantoin may be more effective and can be used for urinary infections in pregnant women

摘要

单纯性尿路感染是社区中抗生素使用最常见的指征之一。然而,可引起该感染的革兰氏阴性菌对抗生素的耐药性越来越强。许多多重耐药菌对两种老抗生素呋喃妥因和磷霉素仍敏感。与新型药物相比,它们的优势在于尿液中浓度高且毒性极小。对于因耐药菌引起的单纯性尿路感染患者,磷霉素是一种潜在的治疗选择。呋喃妥因可能更有效,可用于孕妇的泌尿系统感染。